Neonatologie Scan 2016; 05(01): 59-74
DOI: 10.1055/s-0041-107427
Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Therapeutische Hypothermiebehandlung bei Neugeborenen mit hypoxisch-ischämischer Enzephalopathie

Amelie Waldthaler
,
Andreas W. Flemmer
Further Information

Publication History

Publication Date:
14 March 2016 (online)

Einleitung

Die perinatale Asphyxie ist die Folge eines gestörten plazentaren oder pulmonalen Gasaustauschs. Der gestörte Gasaustausch führt zu Hypoxie und Hyperkapnie, welche die Umstellung auf anaerobe Glukolyse und die Laktatproduktion zur Folge hat. Patienten, die eine perinatale Asphyxie erlitten haben, laufen Gefahr, eine hypoxisch-ischämische Enzephalopathie (HIE) zu entwickeln. Der bisher einzige klinisch etablierte therapeutische Ansatz zur Verminderung der neurologischen Spätfolgen und der Mortalität nach HIE ist die Hypothermiebehandlung. Dank mehrerer großer kontrolliert-randomisierter Studien konnte die therapeutische Hypothermie 2010 als Behandlungsstandard für reife Neugeborene nach perinataler Asphyxie mit moderater bis schwerer HIE etabliert werden [1]. Eine Metaanalyse bestätigte die Reduktion des kombinierten Outcomes Mortalität oder Behinderung im Alter von 18 bis 24 Monaten durch die Hypothermiebehandlung um 25 % [2].

 
  • Literatur

  • 1 Perlman JM, Wyllie J, Kattwinkel J et al. Neonatal Resuscitation Chapter Collaborators. Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010; 122: 516-538
  • 2 Jacobs SE, Berg M, Hunt R et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; 31: 1
  • 3 American College of Obstetricians and Gynecologists (ACOG). Neonatal encephalopathy and cerebral palsy: executive summary. Obstet Gynecol 2004; 103: 780-781
  • 4 Nelson KB, Bingham P, Edwards EM et al. Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry. Pediatrics 2012; 130: 878-886
  • 5 Volpe JJ. Hypoxic-ischemic encephalopathy: clinical aspects. Philadelphia: Saunders Elsevier; 2008
  • 6 Azzopardi D, Brocklehurst P, Edwards D et al. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr 2008; 8: 17
  • 7 Gluckman PD, Wyatt JS, Azzopardi D et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365: 663-670
  • 8 Shankaran S, Laptook AR, Ehrenkranz RA et al. National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574-1584
  • 9 Hassell KJ, Ezzati M, Alonso-Alconada D et al. New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch Dis Child Fetal Neonatal 2015; 10 DOI: 10.1136/archdischild2014-306284.
  • 10 Gunn AJ. Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr 2000; 12: 111-115
  • 11 DuPont TL, Chalak LF, Morriss MC et al. Short-term outcomes of newborns with perinatal acidemia who are not eligible for systemic hypothermia therapy. J Pediatr 2013; 162: 35-41
  • 12 Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976; 33: 696-705
  • 13 Simbruner G, Mittal RA, Rohlmann F et al. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 2010; 126: e771-e778
  • 14 Flemmer AW, Maier RF, Hummler H. AWMF-Leitlinie. Behandlung der neonatalen Asphyxie unter besonderer Berücksichtigung der therapeutischen Hypothermie. Stand 06/2013. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/024-023l_S2k_Behandlung_der_neonatalen_Aphyxie_unter_besonderer_Berücksichtigung_der_therapeutischen_Hypothermie_2013-06.pdf (Zugriff am 20. 12. 2015)
  • 15 al Naqeeb N, Edwards AD, Cowan FM et al. Assessment of neonatal encephalopathy by amplitude-integrated electroencephalography. Pediatrics 1999; 103: 1263-1271
  • 16 Shah DK, Wusthoff CJ, Clarke P et al. Electrographic seizures are associated with brain injury in newborns undergoing therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed 2014; 99: F219-F224
  • 17 Edwards AD, Brocklehurst P, Gunn AJ et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363
  • 18 Laptook A, Tyson J, Shankaran S et al. National Institute of Child Health and Human Development Neonatal Research Network. Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes. Pediatrics 2008; 122: 491-499
  • 19 Azzopardi D, Strohm B, Linsell L et al. UK TOBY Cooling Register. Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK. Analysis of national data. PLoS One 2012; 7: e38504
  • 20 Smit E, Liu X, Jary S et al. Cooling neonates who do not fulfil the standard cooling criteria – short- and long-term outcomes. Acta Paediatr 2015; 104: 138-145
  • 21 Thoresen M, Tooley J, Liu X et al. Time is brain: starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns. Neonatology 2013; 104: 228-233
  • 22 Hoque N, Chakkarapani E, Liu X et al. A comparison of cooling methods used in therapeutic hypothermia for perinatal asphyxia. Pediatrics 2010; 126: e124-e130
  • 23 Shankaran S, Laptook AR, Pappas A et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA 2014; 312: 2629-2639
  • 24 van Rooij LG, Toet MC, van Huffelen AC et al. Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial. Pediatrics 2010; 125: e358-e366
  • 25 Pappas A, Shankaran S, Laptook AR et al. Eunice Kennedy Shriver National Institute of Child Health, Human Development Neonatal Research Network. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr 2011; 158: 752-758
  • 26 Go SL, Singh JM. Pro/con debate: should PaCO2 be tightly controlled in all patients with acute brain injuries?. Crit Care 2013; 17: 202
  • 27 Groenendaal F, De Vooght KM, van Bel F. Blood gas values during hypothermia in asphyxiated term neonates. Pediatrics 2009; 123: 170-172
  • 28 Wood T, Thoresen M. Physiological responses to hypothermia. Semin Fetal Neonatal Med 2015; 20: 87-96
  • 29 Tooley JR, Satas S, Porter H et al. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol 2003; 53: 65-72
  • 30 Angeles DM, Wycliffe N, Michelson D et al. Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome. Pediatr Res 2005; 57: 873-878
  • 31 Roll C, Korinthenberg R, Merkenschlager A et al. AWMF-Leitlinie. Zerebrale Anfälle beim Neugeborenen. Stand 22.08.2012. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/024-011l_S2k_Zerebrale_Anf%C3%A4lle_beim_Neugeborenen_08-2012_1_.pdf (Zugriff am 20. 12. 2015)
  • 32 Chen J, Cai F, Cao J et al. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res 2009; 87: 2898-2907
  • 33 Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998; 132: 345-348
  • 34 Barks JD, Liu YQ, Shangguan Y et al. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010; 67: 532-537
  • 35 Sarkar S, Barks JD, Bapuraj JR et al. Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?. J Perinatol 2012; 32: 15-20
  • 36 van den Broek MP, van Straaten HL, Huitema AD et al. Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia. Neonatology 2015; 107: 150-156
  • 37 Basu SK, Kaiser JR, Guffey D et al. CoolCap Study Group. Hypoglycaemia and hyperglycaemia are associated with unfavourable outcome in infants with hypoxic ischaemic encephalopathy: a post hoc analysis of the CoolCap Study. Arch Dis Child Fetal Neonatal 2015; 17 DOI: 10.1136/archdischild2015-308733.
  • 38 Bhat MA, Shah ZA, Makhdoomi MS et al. Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr 2006; 149: 180-184
  • 39 Wyatt JS, Gluckman PD, Liu PY et al. CoolCap Study Group. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 2007; 119: 912-921
  • 40 van Laerhoven H, de Haan TR, Offringa M et al. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics 2013; 131: 88-98
  • 41 Rutherford M, Srinivasan L, Dyet L et al. Magnetic resonance imaging in perinatal brain injury: clinical presentation, lesions and outcome. Pediatr Radiol 2006; 36: 582-592
  • 42 Harteman JC, Groenendaal F, Toet MC et al. Diffusion-weighted imaging changes in cerebral watershed distribution following neonatal encephalopathy are not invariably associated with an adverse outcome. Dev Med Child Neurol 2013; 55: 642-653
  • 43 Skranes JH, Cowan FM, Stiris T et al. Brain imaging in cooled encephalopathic neonates does not differ between four and 11 days after birth. Acta Paediatr 2015; 104: 752-758
  • 44 Jung da E, Ritacco DG, Nordli DR et al. Early Anatomical Injury Patterns Predict Epilepsy in Head Cooled Neonates With Hypoxic-Ischemic Encephalopathy. Pediatr Neurol 2015; 53: 135-140
  • 45 Martinez-Biarge M, Diez-Sebastian J, Kapellou O et al. Predicting motor outcome and death in term hypoxic-ischemic encephalopathy. Neurology 2011; 76: 2055-2061
  • 46 Shankaran S, Barnes PD, Hintz SR et al. Eunice Kennedy Shriver National Institute of Child Health, Human Development Neonatal Research Network. Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal 2012; 97: F398-F404
  • 47 Sarkar S, Donn SM, Bapuraj JR et al. Distribution and severity of hypoxic-ischaemic lesions on brain MRI following therapeutic cooling: selective head versus whole body cooling. Arch Dis Child Fetal Neonatal 2012; 97: F335-F339
  • 48 Rutherford M, Ramenghi LA, Edwards AD et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial. Lancet Neurol 2010; 9: 39-45
  • 49 Thoresen M, Hellström-Westas L, Liu X et al. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010; 126: e131-e139
  • 50 Csekő AJ, Bangó M, Lakatos P et al. Accuracy of amplitude-integrated electroencephalography in the prediction of neurodevelopmental outcome in asphyxiated infants receiving hypothermia treatment. Acta Paediatr 2013; 102: 707-711
  • 51 Juul SE, Ferriero DM. Pharmacologic neuroprotective strategies in neonatal brain injury. Clin Perinatol 2014; 41: 119-131
  • 52 Chakkarapani E, Dingley J, Liu X et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol 2010; 68: 330-341
  • 53 Dingley J, Tooley J, Liu X et al. Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy: a feasibility study. Pediatrics 2014; 133: 809-818
  • 54 Zhu C, Kang W, Xu F et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009; 124: e218-e226
  • 55 Chaudhari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev 2012; 7: CD006817
  • 56 Kaandorp JJ, van Bel F, Veen S et al. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Arch Dis Child Fetal Neonatal 2012; 97: F162-F166
  • 57 Aly H, Elmahdy H, El-Dib M et al. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 2015; 35: 186-191
  • 58 Wilkinson D, Bain E, Wallace E. Melatonin for women in pregnancy for neuroprotection of the fetus (Protocol). The Cochrane Library. Im Internet: 2013 http://www.researchgate.net/publication/236954442_Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_%28Protocol%29 (Zugriff am 20. 12. 2015)